• OPEN AN ACCOUNT
Indian Indices
Sensex
78,079.96 113.61
( 0.15%)
Global Indices
Nasdaq
53,790.86 -21.99
(-0.04%)
Dow Jones
7,769.71 20.51
(0.26%)
Hang Seng
68,341.16 817.10
(1.21%)
Nikkei 225
10,757.72 -75.43
(-0.70%)
Forex
USD-INR
95.38 0.10
(0.10%)
EUR-INR
110.06 0.02
(0.01%)
GBP-INR
128.81 0.17
(0.13%)
JPY-INR
0.60 0.00
(-0.21%)

EQUITY - MARKET SCREENER

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

maruti suzuki india ltd
Jenburkt Pharmaceuticals standalone net profit declines 24.39% in the June 2026 quarter
Aug 07,2026
Net profit of Jenburkt Pharmaceuticals declined 24.39% to Rs 5.89 crore in the quarter ended June 2026 as against Rs 7.79 crore during the previous quarter ended June 2025. Sales declined 0.06% to Rs 35.51 crore in the quarter ended June 2026 as against Rs 35.53 crore during the previous quarter ended June 2025.

ParticularsQuarter Ended
Jun. 2026Jun. 2025% Var.
Sales35.5135.53 0
OPM %16.9825.19 -
PBDT7.4110.90 -32
PBT6.7710.18 -33
NP5.897.79 -24